vs
STANDARD BIOTOOLS INC.（LAB）与OP Bancorp（OPBK）财务数据对比。点击上方公司名可切换其他公司
OP Bancorp的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$24.3M vs $19.6M），OP Bancorp同比增速更快（13.7% vs -11.5%），OP Bancorp自由现金流更多（$23.4M vs $-23.1M），过去两年OP Bancorp的营收复合增速更高（11.4% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
OP Bancorp是Open Bank的控股母公司，总部位于美国加利福尼亚州，主营社区商业银行业务，提供储蓄支票账户、商业地产贷款、小微企业融资等多元金融产品，主要服务南加州的中小企业、移民群体及零售客户。
LAB vs OPBK — 直观对比
营收规模更大
OPBK
是对方的1.2倍
$19.6M
营收增速更快
OPBK
高出25.2%
-11.5%
自由现金流更多
OPBK
多$46.4M
$-23.1M
两年增速更快
OPBK
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $24.3M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 39.2% |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | 13.7% |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABOPBK
| Q4 25 | — | $24.3M | ||
| Q3 25 | $19.6M | $24.5M | ||
| Q2 25 | $21.8M | $23.7M | ||
| Q1 25 | $40.8M | $22.2M | ||
| Q4 24 | — | $21.3M | ||
| Q3 24 | $22.1M | $20.7M | ||
| Q2 24 | $22.5M | $20.4M | ||
| Q1 24 | $45.5M | $19.6M |
净利润LABOPBK
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $6.7M | ||
| Q2 25 | $-33.5M | $6.3M | ||
| Q1 25 | $-26.0M | $5.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $5.4M | ||
| Q2 24 | $-45.7M | $5.4M | ||
| Q1 24 | $-32.2M | $5.2M |
毛利率LABOPBK
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABOPBK
| Q4 25 | — | 39.2% | ||
| Q3 25 | -168.5% | 39.5% | ||
| Q2 25 | -118.1% | 35.7% | ||
| Q1 25 | -80.8% | 34.6% | ||
| Q4 24 | — | 31.2% | ||
| Q3 24 | -120.9% | 36.5% | ||
| Q2 24 | -134.5% | 37.2% | ||
| Q1 24 | -132.2% | 37.1% |
净利率LABOPBK
| Q4 25 | — | — | ||
| Q3 25 | -177.4% | 27.4% | ||
| Q2 25 | -153.7% | 26.7% | ||
| Q1 25 | -63.8% | 25.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | 26.2% | ||
| Q2 24 | -203.3% | 26.7% | ||
| Q1 24 | -70.6% | 26.7% |
每股收益（稀释后）LABOPBK
| Q4 25 | — | $0.48 | ||
| Q3 25 | $-0.09 | $0.45 | ||
| Q2 25 | $-0.09 | $0.42 | ||
| Q1 25 | $-0.07 | $0.37 | ||
| Q4 24 | — | $0.33 | ||
| Q3 24 | $-0.07 | $0.36 | ||
| Q2 24 | $-0.12 | $0.36 | ||
| Q1 24 | $-0.27 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $167.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $227.9M |
| 总资产 | $539.6M | $2.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABOPBK
| Q4 25 | — | $167.3M | ||
| Q3 25 | $129.4M | $166.7M | ||
| Q2 25 | $158.6M | $205.4M | ||
| Q1 25 | $150.9M | $198.9M | ||
| Q4 24 | — | $134.9M | ||
| Q3 24 | $210.6M | $166.8M | ||
| Q2 24 | $269.8M | $127.7M | ||
| Q1 24 | $287.1M | $139.2M |
总债务LABOPBK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABOPBK
| Q4 25 | — | $227.9M | ||
| Q3 25 | $399.7M | $221.5M | ||
| Q2 25 | $424.5M | $213.7M | ||
| Q1 25 | $454.6M | $210.1M | ||
| Q4 24 | — | $205.0M | ||
| Q3 24 | $489.3M | $203.6M | ||
| Q2 24 | $510.3M | $195.9M | ||
| Q1 24 | $577.3M | $194.7M |
总资产LABOPBK
| Q4 25 | — | $2.7B | ||
| Q3 25 | $539.6M | $2.6B | ||
| Q2 25 | $557.0M | $2.6B | ||
| Q1 25 | $579.6M | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $681.5M | $2.4B | ||
| Q2 24 | $708.7M | $2.3B | ||
| Q1 24 | $777.7M | $2.2B |
负债/权益比LABOPBK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $23.4M |
| 自由现金流率自由现金流/营收 | -118.1% | 96.2% |
| 资本支出强度资本支出/营收 | 4.5% | 11.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $43.3M |
8季度趋势，按日历期对齐
经营现金流LABOPBK
| Q4 25 | — | $26.2M | ||
| Q3 25 | $-22.2M | $23.9M | ||
| Q2 25 | $-20.7M | $-7.0M | ||
| Q1 25 | $-30.3M | $5.6M | ||
| Q4 24 | — | $31.2M | ||
| Q3 24 | $-27.9M | $13.3M | ||
| Q2 24 | $-39.0M | $15.8M | ||
| Q1 24 | $-62.5M | $-3.2M |
自由现金流LABOPBK
| Q4 25 | — | $23.4M | ||
| Q3 25 | $-23.1M | $23.4M | ||
| Q2 25 | $-22.6M | $-7.7M | ||
| Q1 25 | $-35.3M | $4.2M | ||
| Q4 24 | — | $29.7M | ||
| Q3 24 | $-30.1M | $12.8M | ||
| Q2 24 | $-41.0M | $15.7M | ||
| Q1 24 | $-63.3M | $-3.2M |
自由现金流率LABOPBK
| Q4 25 | — | 96.2% | ||
| Q3 25 | -118.1% | 95.6% | ||
| Q2 25 | -103.6% | -32.5% | ||
| Q1 25 | -86.6% | 19.0% | ||
| Q4 24 | — | 139.0% | ||
| Q3 24 | -136.4% | 61.5% | ||
| Q2 24 | -182.2% | 77.0% | ||
| Q1 24 | -138.9% | -16.6% |
资本支出强度LABOPBK
| Q4 25 | — | 11.5% | ||
| Q3 25 | 4.5% | 2.3% | ||
| Q2 25 | 8.7% | 3.0% | ||
| Q1 25 | 12.4% | 6.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | 10.2% | 2.8% | ||
| Q2 24 | 8.6% | 0.4% | ||
| Q1 24 | 1.7% | 0.5% |
现金转化率LABOPBK
| Q4 25 | — | — | ||
| Q3 25 | — | 3.57× | ||
| Q2 25 | — | -1.10× | ||
| Q1 25 | — | 1.02× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.45× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | -0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
OPBK
暂无分部数据
